MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 48 filers reported holding MILLENDO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,000 | -77.3% | 3,000 | -28.0% | 0.00% | – |
| Q1 2020 | $22,000 | -78.0% | 4,165 | -72.6% | 0.00% | – |
| Q4 2019 | $100,000 | +488.2% | 15,175 | +461.8% | 0.00% | – |
| Q3 2019 | $17,000 | -91.6% | 2,701 | -84.6% | 0.00% | – |
| Q2 2019 | $202,000 | +445.9% | 17,490 | +604.7% | 0.00% | – |
| Q1 2019 | $37,000 | – | 2,482 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,396,615 | $20,949,000 | 5.04% |
| GREAT POINT PARTNERS LLC | 1,288,093 | $19,321,000 | 1.91% |
| Bpifrance SA | 1,078,670 | $16,180,000 | 1.84% |
| Prosight Management, LP | 270,762 | $4,061,000 | 1.78% |
| NEA Management Company, LLC | 1,766,779 | $26,502,000 | 1.38% |
| ADAMS STREET PARTNERS LLC | 459,146 | $6,543,000 | 1.27% |
| Samsara BioCapital, LLC | 45,101 | $677,000 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,860 | $925,000 | 0.34% |
| PA Capital LLC | 15,263 | $229,000 | 0.24% |
| Fondren Management LP | 14,478 | $217,000 | 0.17% |